These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 7028776)

  • 1. Differential effects of tolbutamide on first and second phase insulin secretion in noninsulin-dependent diabetes mellitus.
    Pfeifer MA; Halter JB; Beard JC; Porte D
    J Clin Endocrinol Metab; 1981 Dec; 53(6):1256-62. PubMed ID: 7028776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin responses to nonglucose stimuli in non-insulin-dependent diabetes mellitus during a tolbutamide infusion.
    Pfeifer MA; Halter JB; Beard JC; Judzewitsch R; Porte D
    Diabetes; 1982 Feb; 31(2):154-9. PubMed ID: 6759232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The regulation of glucose-induced insulin secretion by pre-stimulus glucose level and tolbutamide in normal man.
    Pfeifer MA; Graf RJ; Halter JB; Porte D
    Diabetologia; 1981 Sep; 21(3):198-205. PubMed ID: 7028551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of salicylate, tolbutamide, and prostaglandin E2 on insulin responses to glucose in noninsulin-dependent diabetes mellitus.
    Giugliano D; Ceriello A; Saccomanno F; Quatraro A; Paolisso G; D'Onofrio F
    J Clin Endocrinol Metab; 1985 Jul; 61(1):160-6. PubMed ID: 3923028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of glucagon secretion during a tolbutamide infusion in normal and noninsulin-dependent diabetic subjects.
    Pfeifer MA; Beard JC; Halter JB; Judzewitsch R; Best JD; Porte D
    J Clin Endocrinol Metab; 1983 Mar; 56(3):586-91. PubMed ID: 6337181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Propranolol does not inhibit sulphonylurea-stimulated insulin secretion in patients with non-insulin dependent diabetes mellitus.
    Groop L; Tötterman KJ
    Acta Endocrinol (Copenh); 1982 Jul; 100(3):410-5. PubMed ID: 7051722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new method for comparing portal and peripheral venous insulin delivery in humans: tolbutamide versus insulin infusion.
    Lewis GF; Steiner G; Polonsky KS; Weller B; Zinman B
    J Clin Endocrinol Metab; 1994 Jul; 79(1):66-70. PubMed ID: 8027255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterisation of the effect of intravenous infusion of glucose and tolbutamide on the insulin delivery rate in man.
    Asano T; Sasaki H; Okumura M
    Diabetologia; 1978 Sep; 15(3):159-64. PubMed ID: 700280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potentiation of insulin secretion to nonglucose stimuli in normal man by tolbutamide.
    Pfeifer MA; Halter JB; Graf R; Porte D
    Diabetes; 1980 May; 29(5):335-40. PubMed ID: 6991327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic chlorpropamide therapy of noninsulin-dependent diabetes augments basal and stimulated insulin secretion by increasing islet sensitivity to glucose.
    Judzewitsch RG; Pfeifer MA; Best JD; Beard JC; Halter JB; Porte D
    J Clin Endocrinol Metab; 1982 Aug; 55(2):321-8. PubMed ID: 7045153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glipizide versus tolbutamide, an open trial. Effects on insulin secretory patterns and glucose concentrations.
    Fineberg SE; Schneider SH
    Diabetologia; 1980 Jan; 18(1):49-54. PubMed ID: 6988265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of sulfonylurea's stimulation of insulin secretion in vivo: selective amplification of insulin secretory burst mass.
    Pørksen NK; Munn SR; Steers JL; Schmitz O; Veldhuis JD; Butler PC
    Diabetes; 1996 Dec; 45(12):1792-7. PubMed ID: 8922367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of weight loss and reduced hyperglycemia on the kinetics of insulin secretion in obese non-insulin dependent diabetes mellitus.
    Gumbiner B; Polonsky KS; Beltz WF; Griver K; Wallace P; Brechtel G; Henry RR
    J Clin Endocrinol Metab; 1990 Jun; 70(6):1594-602. PubMed ID: 2189885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diminished B cell secretory capacity in patients with noninsulin-dependent diabetes mellitus.
    Ward WK; Bolgiano DC; McKnight B; Halter JB; Porte D
    J Clin Invest; 1984 Oct; 74(4):1318-28. PubMed ID: 6384269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of the discontinuation of long-term sulfonylurea treatment on blood glucose and insulin secretion in noninsulin-dependent diabetes mellitus.
    Sumi S; Ichihara K; Nonaka K; Tarui S
    Endocrinol Jpn; 1982 Feb; 29(1):41-7. PubMed ID: 7049684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of long-term tolbutamide treatment on glucose tolerance and insulin secretion in maturity-onset diabetes without obesity.
    Lauvaux JP; Mandart G; Heymans G; Ooms HA
    Horm Metab Res; 1972 Mar; 4(2):58-62. PubMed ID: 5028221
    [No Abstract]   [Full Text] [Related]  

  • 17. Acute-phase insulin secretion and glucose tolerance in young and aged normal men and diabetic patients.
    Palmer JP; Ensinck JW
    J Clin Endocrinol Metab; 1975 Sep; 41(3):498-503. PubMed ID: 1159058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypoglycemic and hypotriglyceridemic effects of tolbutamide in triphenyltin chloride-induced diabetic rabbits.
    Watanabe M; Watanabe K; Matsui H
    Vet Hum Toxicol; 2002 Jun; 44(3):140-4. PubMed ID: 12046964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin secretion in diabetes mellitus.
    Pfeifer MA; Halter JB; Porte D
    Am J Med; 1981 Mar; 70(3):579-88. PubMed ID: 7011013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sulfonylurea compounds uncouple the glucose dependence of the insulinotropic effect of glucagon-like peptide 1.
    de Heer J; Holst JJ
    Diabetes; 2007 Feb; 56(2):438-43. PubMed ID: 17259389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.